comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 10:59:38 - browse：88

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： With trial win, GSK could get blood cancer drug back on market

focus

WSS

Shifting the focus from loneliness to social health

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Letters to First Opinion on caregivers, digital health, and more

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Novel spinal cord stimulator treats paralysis without surgery

entertainment

comprehensive

leisure time

How one medical school became remarkably diverse

The creative science of coining drug names

Guidelines to prevent youth baseball injuries need more muscle

Crowdfunding for medical bills sidesteps core problem, author says

State Dept. review finds Biden bears some blame for Afghanistan failures

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

See how much Covid

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Wikipedia

Deliver public health messages at the right time

HIV drugs protect against transmission, even in unprotected sex

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Deliver public health messages at the right time

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

knowledge

focus

leisure time

hotspot